Results: 17

Vascular endothelial growth factor gene variations as a risk predictor in disc degeneration

Einstein (Säo Paulo); 15 (4), 2017
ABSTRACT Objective: To evaluate the frequency of polymorphisms in the vascular endothelial growth factor (VEGF) gene, as well as to identify a potential risk haplotype among the polymorphic regions in this gene in patients with disc degeneration and in the Control Group. Methods: This study analyzed a ...

Biomechanic and histologic analysis of fibroblastic effects of tendon to bone healing by transforming growth factor β1 (TGF-β1) in rotator cuff tears

Acta cir. bras; 32 (12), 2017
Abstract Purpose: To evaluate the effect of transforming growth factor β1 (TGF-β1) on tendon-to-bone reconstruction of rotator cuff tears. Methods: Seventy-two rat supraspinatus tendons were transected and reconstructed in situ. At 8 and 16 weeks, specimens of three groups; that is control,...

Effects of topical and subconjunctival use of bevacizumab on corneal neovascularization in rabbits' eyes

Arq. bras. oftalmol; 80 (4), 2017
ABSTRACT Purpose: To evaluate and compare the effects of topical application and subconjunctival injection of bevacizumab on corneal neovascularization (CNV) in rabbits' eyes after chemical burning of the cornea. Methods: The animals were randomly distributed into four groups of five animals. In one gr...

Effects of insulin-like growth factor-1 on random pattern skin flap survival in rats

Acta cir. bras; 31 (8), 2016
ABSTRACT PURPOSE: To investigate the effects of pharmacological delay with insulin-like growth factor-1 (IGF-1) on skin flap survival. METHODS: Thirty Sprague-Dawley rats were submitted to dorsal skin flap (3x9 cm). Seven days before the surgery, the animals were subdivided into three groups of 10 rats...

Perspectivas farmacológicas futuras en el tratamiento de la degeneración macular relacionada a la edad (DMRE) neovascular. Parte 1: fármacos en estudios clínicos

Objetivos: Presentar una revisión de los nuevos y posibles objetivos de tratamiento farmacológicos para la degeneración macular relacionada a la edad neovascul r y el estado de los fármacos en estudios clínicos. Diseño del estudio: Revisión de tema. Métodos: Se realizó una búsqueda de la litera...

Study on vascular endothelial growth factor and its receptor in the vitreous of diabetic rats

West Indian med. j; 62 (9), 2013
OBJECTIVE: To investigate the vitreous level of vascular endothelial growth factor (VEGF) and kinase insert domain-containing receptor (KDR) in diabetic rats, and to explore the role of VEGF and KDR in diabetic retinopathy. METHODS: Eighty-four adult Wistar rats were randomly divided into two groups. Fif...

Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy

Medicina (B.Aires); 60 Suppl 2 (), 2000
Of the numerous growth factors and cytokines that have been shown to have angiogenic effects, vascular endothelial growth factor (VEGF), also known as vascular permeability factor (VPF), appears to be a key factor in pathological situations which involve neovascularization as well as enhanced vascular pe...